Furthermore, abnormally low liver CPS1 activity has been reported in patients with genetically demonstrated NAGSD[29,191] and in the hyperinsulinism-hyperammonemia syndrome[192] (a defect involving glutamate dehydrogenase). Here, CPS1 is linked to hyperinsulinism.